Profit Planning for Go Public Pharmaceutical Companies

Main Article Content

Renny Mointi
ady Kurnia

Abstract

The purpose of this study is to analyze differences in the financial performance of pharmaceutical companies listed on the Indonesia Stock Exchange. This type of research is descriptive research with a quantitative approach, the data source used is secondary data, namely data in the form of company’s annual financial reports from 2015 - 2019 attached to the IDX website. Data collection techniques in this study use documentation techniques. Research population Pharmaceutical companies listed on the Indonesia Stock Exchange, sampling using purposive sampling method, namely PT. Kalbe Farma Tbk (KLBF) PT. Kimia Farma, (KAEF), and PT. Pharos Tbk (PEHA). The data analysis technique used in this research is the Profitability Ratio Net Profit Margin (NPM), Return On Asset (ROA), Return On Equity (ROE) analysis technique, namely 5 periods of financial statements for each of 3 pharmaceutical companies using standard ratio analysis. industry profitability by cashmere. The results showed that the differences in the financial performance of 3 pharmaceutical companies listed on the IDX were seen from the profitability ratio of Net Profit Margin (NPM) for 5 years, namely PT. Kalbe Farma Tbk, PT. Kimia Farma Tbk is not very good and PT. Pharos Indonesia, Tbk is not good enough. Return On Asset (ROA). PT. Kalbe Farma Tbk, PT. Kimia Farma Tbk is not very good and PT. Pharos Indonesia, Tbk is not very good. Return On Equity (ROE) The financial performance of PT. Kalbe Farma Tbk, PT. Kimia Farma Tbk is not very good and PT. Pharos Indonesia, Tbk is not very good.

Article Details

How to Cite
Mointi, R., & Kurnia, ady. (2021). Profit Planning for Go Public Pharmaceutical Companies. Economy Deposit Journal (E-DJ), 3(1), 28-39. https://doi.org/10.36090/e-dj.v3i1.1006
Section
Articles

References

Adam, M. (2015). Analisis Laporan Keuangan On Line Perusahaan Sektor Pertambangan Di Bursa Efek Indonesia. Jurnal Manajemen Dan Bisnis Sriwijaya, 13(2).
Asyikin, J., & A Tanu, V. S. (2016). Analisis Perbandingan Kinerja Keuangan Antara Perusahaan Farmasi Milik Pemerintah (Bumn) Dengan Perusahaan Farmasi Swasta Yang Terdaftar Di Bursa Efek Indonesia. Ilmiah Bisnis Dan Keuangan, 1(1), 1978-2721.
Elliyana, E. (2012) Relationship between Return on Asset (RoA) and Stock Return (SR) for Agribusiness Go Public Company. International Journal of Scientific Development and Research IJSDR1710022 3(2), 96-98
Farida Efriyanti, E. (2012). Analisis Kinerja Keuangan Sebagai Dasar Investor Dalam Menanamkan Modal. Jurnal Akuntansi Dan Keuangan, 3(2).
Kasmir. (2014). Analisis Laporan Keuangan. (Jakarta: Rajawali Pers.
Martani, D. (2014). Akuntansi Keuangan Menengah Berbasis Psak. Jakarta: Salemba Empat.
Ratningsih, & Alawiyah, T. (2017). Analisis Kinerja Keuangan Dengan Menggunakan. Jurnal Ilmiah Manajemen Fakultas Ekonomi, 3(2).
Rhamadana, R. B. (2016). Analisis Rasio Keuangan Untuk Menilai Kinerja Keuangan. Jurnal Ilmu Dan Riset Manajemen,, 5(7), Xx.
Vitri, A. S. (2012). Vitri, A. S. (2012). Analisis Laporan Keuangan Sebagai Alat Untuk Menilai Kinerja Pada Pt. Bag. Surabaya: Stie Perbanas.
Wiagustini, N. L. (2015). Pengaruh Risiko Bisnis Dan Ukuran Perusahaan Terhadap Struktur Modal Dan Nilai Perusahaan Pada Perusahaan Farmasi Di Bursa Efek Indonesia. Matrik: Jurnal Manajemen, Strategi Bisnis Dan Kewirausahaan.